Embla Medical

	21/10 08:06 af ProInvestorNEWS	Der kommer en opgraderingscyklus, men det kommer til at ske gradvist, siger Sveinn Sölvason, der er administrerende direktør i Embla Medicals, og som indtil videre holder fast i vækstmålene. Originalartikel: Børsen, 21. oktober, side 10
	21/10 08:05 af ProInvestorNEWS	Bionik-proteser er både dyrere og mere lønsomme end de mekaniske proteser. Hvor en bionik-protese, som har indbygget batteri, computer og en motor, i dag koster omkring 10.000-20.000 dollar, koster en mekanisk knæprotese derimod 2000-4000 dollar.
	21/10 08:05 af ProInvestorNEWS	Det må formodes, at Embla Medical i de kommende kvartaler vil nyde godt af denne ændring i adgangen til de mere avancerede og dyre produkter i USA, vurderer Niels Granholm-Leth, der er aktieanalysechef i investeringsbanken Carnegie, over for Børsen
	21/10 08:05 af ProInvestorNEWS	i dag kl. 08:00 ∙ MarketWire Proteseselskabet Embla Medicals ser vækstmulighed i forbedret tilskudssituation i USA. Flere får adgang til avancerede proteser, og det kan sikre Embla Medicals vækstløft næste år. Det skriver Børsen. For islandske Embla Medical kan der være et vækstløft på vej. En ny tilskudsordning i USA fra det offentlige amerikanske sundhedsprogram Medicare betyder, at flere amerikanere snart kan få tilskud til de mere avancerede bionik-proteser.
	21/10 07:46 af B.Andersen	Mon ikke omtalen sætter skub i kursen i dag?
	21/10 07:42 af ProInvestorNEWS	Børsen: Corona satte dybe spor i Demant-ejers islandske børsselskab: Lysning i USA kan vende billedet Flere får adgang til avancerede proteser i USA. Det kan sikre Embla Medical et løft i væksten næste år (link)
	21/10 07:39 af ProInvestorNEWS	Medwatch: (link)
	21/10 05:56 af ProInvestorNEWS	Børsen: Embla Medicals ser vækstmulighed i forbedret tilskudssituation i USA. Flere får adgang til avancerede proteser, og det kan sikre Embla Medicals vækst næste år. (Side 10)
	17/10 15:02 af ProInvestorNEWS	OBS: Embla Medical har en betalt digital IR-aftale med ProInvestor.com
	17/10 15:01 af ProInvestorNEWS	Webcast på dansk fra Økonomisk Ugebrev (link)
	17/10 15:00 af ProInvestorNEWS	Kilde: Klaus Sindahl Head of Investor Relations Embla-Medical
	17/10 14:59 af ProInvestorNEWS	The business recorded USD 23m in sales in 2023 (mainly Germany) and Embla will utilize its commercial footprint to expand the business globally. F&G is accretive.
	17/10 14:58 af ProInvestorNEWS	Neuro Orthotics Back in January this year Embla acquired a German Neuro Orthotic Business Fior & Gentz for EUR 100m. F&G develops and manufacture "technical orthotics" (bionic joints) for patients suffering from disabled mobility following e.g. stroke, MS, CP. Neuro Orthotics is perhaps 10-20 years after prosthetics in terms of awareness and reimbursement but with great growth potential.
	17/10 14:58 af ProInvestorNEWS	Innovation agenda 5% of revenue (USD ~30m) is invested in R&D annually with product launches every year. 70-80% of sales in prosthetics is reoccuring as the replacement cyle typically runs for 3-4 years. Two new bionic knee solutions (NAVII and ICON) were launched end of Q2 2024.
	17/10 14:58 af ProInvestorNEWS	Growth'27: Late March 2023, Embla Medical launched a new five-year growth ambition of 7-10% average growth (organic growth of 5-7% and M&A of 2-3%).
	17/10 14:57 af ProInvestorNEWS	Strong growth case with increasing Earnings and solid cash flow generation Since listing in 1999 the business has grown at ~17% CAGR driven by organic sales and acquisitions ~85% of EBIT converted into FCF in the past decade. For 2024 the Company is guiding 6-8% organic growth and ~20% EBITDA (22% in Q2 2024; up 3pp vs Q3 2023).
	17/10 14:57 af ProInvestorNEWS	Why is Embla an attractive case right now? US Medicare implemented extended coverage in September 2024 Coverage expansion will allow less mobile/low-active amputees (K2 patients) access to advanced bionic devices (previously restricted to K3/K4). The new reform is expected to contribute meaningfully to Embla's organic growth over the next 3-5 years
	17/10 14:55 af ProInvestorNEWS	Q2 2024 Report 2024 (July 23, 2024) (link)
	17/10 14:54 af ProInvestorNEWS	Q2 2024 Recent Embla Medical corporate deck (July 23, 2024) Roadshow presentation: (link)
	17/10 14:37 af ProInvestorNEWS	Velkommen til Embla Medical chat.